30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mike Mulroy

Insider profile

Currently holds positions in Mallinckrodt Ard Inc, Lineage Cell Therapeutics Inc and Asterias Biotherapeutics Inc

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Executive Vice President - Strategic Affairs, General Counsel Mallinckrodt Ard Inc Feb. 17, 2014 -
Independent Director Lineage Cell Therapeutics Inc Oct. 4, 2014 -
President, Chief Executive Officer Asterias Biotherapeutics Inc March 8, 2019 -
President, Chief Executive Officer, Director Asterias Biotherapeutics Inc June 26, 2017 - March 8, 2019
Independent Director Comarco Inc Jan. 1, 2011 - Aug. 25, 2014
Chief Financial Officer, Executive Vice President, General Counsel, Corporate Secretary Mallinckrodt Ard Inc July 31, 2013 - Feb. 17, 2014
Chief Financial Officer, Senior Vice President, General Counsel, Corporate Secretary Mallinckrodt Ard Inc Jan. 10, 2011 - July 31, 2013

Mike Mulroy's trades of Lineage Cell Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-25 2024-11-22 B Purchase
84,420 +14.4%
25.11
US$4,996,442
84,420 +14.4% 25.11 US$4,996,442
2022-03-25 2022-03-24 B Purchase
25,139 -25.9%
181.89
US$2,777,531
25,139 -25.9% 181.89 US$2,777,531